Traino AC - Search Results

1

Dosimetry for nonuniform activity distributions: a method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations.

Traino AC, Marcatili S, Avigo C, Sollini M, Erba PA, Mariani G. Traino AC, et al. Med Phys. 2013 Apr;40(4):042505. doi: 10.1118/1.4794473. Med Phys. 2013. PMID: 23556921

2

A minimally invasive method to evaluate 131I kinetics in blood.

Traino AC, Di Martino F, Boni G, Mariani G, Lazzeri M. Traino AC, et al. Radiat Prot Dosimetry. 2004;109(3):249-52. doi: 10.1093/rpd/nch041. Radiat Prot Dosimetry. 2004. PMID: 15254330

3

A dosimetric approach to patient-specific radioiodine treatment of Graves' disease with incorporation of treatment-induced changes in thyroid mass.

Traino AC, Di Martino F, Lazzeri M. Traino AC, et al. Med Phys. 2004 Jul;31(7):2121-7. doi: 10.1118/1.1763411. Med Phys. 2004. PMID: 15305466 Clinical Trial.

4

A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.

Traino AC, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, Mariani G, Lazzeri M. Traino AC, et al. Phys Med Biol. 2005 May 7;50(9):2181-91. doi: 10.1088/0031-9155/50/9/018. Epub 2005 Apr 20. Phys Med Biol. 2005. PMID: 15843745 Clinical Trial.

5

Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.

Grosso M, Traino A, Boni G, Banti E, Della Porta M, Manca G, Volterrani D, Chiacchio S, AlSharif A, Borsò E, Raschillà R, Di Martino F, Mariani G. Grosso M, et al. Cancer Biother Radiopharm. 2005 Apr;20(2):218-23. doi: 10.1089/cbr.2005.20.218. Cancer Biother Radiopharm. 2005. PMID: 15869459

6

Ion recombination correction for very high dose-per-pulse high-energy electron beams.

Di Martino F, Giannelli M, Traino AC, Lazzeri M. Di Martino F, et al. Among authors: traino ac. Med Phys. 2005 Jul;32(7):2204-10. doi: 10.1118/1.1940167. Med Phys. 2005. PMID: 16121574

7

A study of the possibility of curing Graves' disease based on the desired reduction of thyroid mass (volume) as a consequence of 131I therapy: a speculative paper.

Traino AC, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, Mariani G, Lazzeri M. Traino AC, et al. Nucl Med Commun. 2006 May;27(5):439-46. doi: 10.1097/00006231-200605000-00005. Nucl Med Commun. 2006. PMID: 16609355

8

A dosimetric algorithm for patient-specific 131I therapy of thyroid cancer based on a prescribed target-mass reduction.

Traino AC, Di Martino F. Traino AC, et al. Phys Med Biol. 2006 Dec 21;51(24):6449-56. doi: 10.1088/0031-9155/51/24/011. Epub 2006 Nov 30. Phys Med Biol. 2006. PMID: 17148828

9

Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry.

Traino AC, Ferrari M, Cremonesi M, Stabin MG. Traino AC, et al. Phys Med Biol. 2007 Sep 7;52(17):5231-48. doi: 10.1088/0031-9155/52/17/009. Epub 2007 Aug 15. Phys Med Biol. 2007. PMID: 17762083

10

Accuracy of two simple methods for estimation of thyroidal 131I kinetics for dosimetry-based treatment of Graves' disease.

Traino AC, Xhafa B. Traino AC, et al. Med Phys. 2009 Apr;36(4):1212-8. doi: 10.1118/1.3093237. Med Phys. 2009. PMID: 19472628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters